08:00 , Mar 2, 2015 |  BC Week In Review  |  Company News

Diagnoplex, Novigenix deal

Novigenix purchased Diagnoplex’s Colox , which is approved in Europe to detect colorectal cancer and pre-cancerous lesions using a blood test. Novigenix said it owns all of Diagnoplex’s assets and declined to provide financial details....
07:00 , Mar 10, 2014 |  BC Week In Review  |  Company News

Diagnoplex, Unilabs sales and marketing update

Unilabs launched Diagnoplex's Colox colon cancer screening test in Switzerland. The test can detect colorectal cancer from a blood sample by quantifying 29 biomarkers through quantitative RT-PCR. Unilabs will process the test at its diagnostic...
07:00 , Sep 30, 2013 |  BC Week In Review  |  Company News

Diagnoplex, Unilabs sales and marketing update

Diagnoplex granted Unilabs rights to commercialize its Colox blood-based diagnostic test for colorectal cancer within the Unilabs network, which covers Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden, Switzerland and the U.K. Unilabs said...
07:00 , May 4, 2009 |  BioCentury  |  Product Development

From Micro to Macro

Since its founding in 2000, Rosetta Genomics Ltd. has been building an IP estate and developing a portfolio of tests that measure expression of microRNA to diagnose disease. Now that Rosetta has launched its first...
07:00 , Jun 23, 2008 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Diagnoplex S.a.r.l. Epalinges, Switzerland Technology: Colox blood-based diagnostic test for colorectal cancer Disease focus: Cancer Clinical status: Pilot Founded: 2005 by Stavros Therianos, Jacques Essinger, Jean-Pierre Rosat, Novartis Venture Fund University collaborators: Swiss Institute for...
07:00 , Jun 23, 2008 |  BioCentury  |  Emerging Company Profile

Diagnoplex: Simplifying colon screening

The gold standard for colorectal cancer diagnostics is colonoscopy, yet the invasive nature of the test consistently leads to poor compliance among the at-risk population. Diagnoplex S.a.r.l. believes its non-invasive test will not only improve...